Citation 86234

ANIS,I: ANIS,E: AHMED,S: MUSTAFA,G: MALIK,A: AMTUL,Z: ATTA-U-RAHMAN:. (2001). THROMBIN INHIBITORY CONSTITUENTS FROM DURANTA REPENS.. 84(3)

Citation Details

Title	THROMBIN INHIBITORY CONSTITUENTS FROM DURANTA REPENS.
Authors	ANIS,I: ANIS,E: AHMED,S: MUSTAFA,G: MALIK,A: AMTUL,Z: ATTA-U-RAHMAN:
Year	2001
Volume	84
Issue	3

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Duranta repens (VERBENACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVONE,3-4'-7-TRIHYDROXY-3'-(4-HYDROXY-3-METHYL-BUTYL)-5-6-DIMETHOXY:	None
2	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-4'-7-TRIHYDROXY-3'-(4-HYDROXY-3-METHYL-BUTYL)-5-6-DIMETHOXY:	ACTIVE
3	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-4'-7-TRIHYDROXY-3'-(4-HYDROXY-3-METHYL-BUTYL)-5-6-DIMETHOXY:	INACTIVE
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVONE,3-7-DIHYDROXY-3'-(4-HYDROXY-3-METHYL-BUTYL)-4'-5-6-TRIMETHOXY:	None
5	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-7-DIHYDROXY-3'-(4-HYDROXY-3-METHYL-BUTYL)-4'-5-6-TRIMETHOXY:	INACTIVE
6	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-7-DIHYDROXY-3'-(4-HYDROXY-3-METHYL-BUTYL)-4'-5-6-TRIMETHOXY:	INACTIVE
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLERODA-3-13(16)-14-TRIEN-18-OIC ACID,5-BETA-8-BETA-9-BETA-10-ALPHA: 6-BETA-HYDROXY-15-16-EPOXY:	None
8	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CLERODA-3-13(16)-14-TRIEN-18-OIC ACID,5-BETA-8-BETA-9-BETA-10-ALPHA: 6-BETA-HYDROXY-15-16-EPOXY:	ACTIVE
9	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CLERODA-3-13(16)-14-TRIEN-18-OIC ACID,5-BETA-8-BETA-9-BETA-10-ALPHA: 6-BETA-HYDROXY-15-16-EPOXY:	ACTIVE
10	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CLERODA-3-13(16)-14-TRIEN-18-OIC ACID,5-BETA-8-BETA-9-BETA-10-ALPHA: 2-BETA-HYDROXY-15-16-EPOXY:	None
11	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CLERODA-3-13(16)-14-TRIEN-18-OIC ACID,5-BETA-8-BETA-9-BETA-10-ALPHA: 2-BETA-HYDROXY-15-16-EPOXY:	INACTIVE
12	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CLERODA-3-13(16)-14-TRIEN-18-OIC ACID,5-BETA-8-BETA-9-BETA-10-ALPHA: 2-BETA-HYDROXY-15-16-EPOXY:	INACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OF	EUPALITIN	None
14	THROMBIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPALITIN	ACTIVE
15	TRYPSIN INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPALITIN	ACTIVE

Show SPARQL Queries (1)